` BHST (Bioharvest Sciences Inc) vs S&P 500 Comparison - Alpha Spread

B
BHST
vs
S&P 500

Over the past 12 months, BHST has outperformed S&P 500, delivering a return of +20% compared to the S&P 500's +13% growth.

Stocks Performance
BHST vs S&P 500

Loading
BHST
S&P 500
Add Stock

Performance Gap
BHST vs S&P 500

Loading
BHST
S&P 500
Difference
www.alphaspread.com

Performance By Year
BHST vs S&P 500

Loading
BHST
S&P 500
Add Stock

Competitors Performance
Bioharvest Sciences Inc vs Peers

S&P 500
BHST
SUNPHARMA
DD
SDZ
300765
Add Stock

Bioharvest Sciences Inc
Glance View

Market Cap
119.6m USD
Industry
N/A

BioHarvest Sciences, Inc. develops bio farming technology. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-08-05. The firm operates through two segments: Superfruits and Cannabis. The Superfruits segment is engaged in the development, design, manufacture and marketing of VINIA for the retail market. The Cannabis segment is focused on the development, design, manufacture and marketing of medical cannabis. Its nutraceutical superfruits product, VINIA, is made of red grape (Vitis vinifera) cells grown in the Company's bioreactor facility. The firm is also engaged in research and development of its BioFarming technology for use in the cannabis industry. This plant-based technology produces cannabis cells. The firm is engaged in the sales of VINIA in the Israeli and United States markets. Its subsidiaries include BioHarvest Inc., Dolarin Ltd. (Dolarin) and Superfood Nutraceuticals Inc. (Superfood).

BHST Intrinsic Value
13.98 USD
Undervaluation 51%
Intrinsic Value
Price
B
Back to Top